
Neogen Corporation
NEOGNASDAQHealthcareMedical - Devices
Previous close
$11.95
+$0.12 · +1.01%
NEOG company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
47
Fair Value
Momentum
57
Neutral
Sentiment
53
Mixed
Risk resilience
52
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteNeogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Mikhael Nassif
- Listed since
- Aug 23, 1989
- Employees
- 2,636
Market position
Day range
Current $11.95
52-week range
Current $11.95
- Open
- $11.885
- Previous close
- $11.83
- Volume
- 1.21M
- 0.54× average
- Average volume
- 2.23M
- Average daily volume
- Market cap
- 2.61B USD
- Beta
- 1.77
- Market reference 1
- 50-day average
- $10.2162
- +16.97% above average
- 200-day average
- $9.095
- +31.39% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 2.55B USD
- EV / EBITDA
- 14.95×
- Earnings yield
- -0.41%
- Free cash flow yield
- 1.64%
Profitability & efficiency
- Return on equity
- -0.38%
- Return on assets
- -0.24%
- Return on invested capital
- -0.59%
Financial health
- Current ratio
- 3.82×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 870.4M USD | 894.66M USD | 924.22M USD | 822.45M USD | 527.16M USD |
| Cost of goods sold | 461.9M USD | 473.29M USD | 461.59M USD | 416.49M USD | 284.15M USD |
| Gross profit | 408.5M USD | 421.38M USD | 462.64M USD | 405.96M USD | 243.01M USD |
| Research and development | 18.4M USD | 21.09M USD | 22.48M USD | 26.04M USD | 17.05M USD |
| Selling, general, and administrative | 411.7M USD | 401.97M USD | 382.76M USD | 342.4M USD | 167.35M USD |
| Operating expenses | 430.1M USD | 411.96M USD | 385.21M USD | 368.44M USD | 184.4M USD |
| Interest income | — | 3.11M USD | 6.36M USD | 3.17M USD | 1.34M USD |
| Interest expense | 57.6M USD | 71.62M USD | 73.39M USD | 55.96M USD | 72K USD |
| Depreciation and amortization | 121.9M USD | 125.67M USD | 121.23M USD | 88.38M USD | 23.69M USD |
| Operating income | −21.6M USD | 9.42M USD | 77.43M USD | 37.52M USD | 58.62M USD |
| Net income | −7.9M USD | −1.09B USD | −9.42M USD | −22.87M USD | 48.31M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 36%
- 4 beats, 7 misses, 0 met estimates
- Average EPS surprise
- -535.52%
- 11 comparable reports
- Latest EPS result
- 0.09
- Estimate 0.06 · Beat by 58.81%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$13.00
8.79% upsideRating distribution
11 ratingsNEOG news
NEOG peers
ETFs holding NEOG
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR157.14M0.14%111.19B USD0.06%$147.31+0.64%
Vanguard Morningstar Total Stock Market ETFVTI83.9M0.00%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM67.21M0.08%81.62B USD0.19%$299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB60.25M0.03%183.4B USD0.03%$304.76+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR38.27M0.06%68.3B USD0.05%$249.18+0.68%
Vanguard Extended Market ETFVXF30.15M0.03%93.7B USD0.05%$245.53+0.82%
iShares Russell 2000 Value ETFIWN24.45M0.17%14.66B USD0.24%$224.81+0.45%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM24.18M0.14%17.03B USD0.03%$57.28+0.61%
iShares Core S&P Small-Cap ETFIJR- Market value
- 157.14M
- Weight
- 0.14%
- AUM
- 111.19B USD
- Expense ratio
- 0.06%
- Price / 1D
- $147.31+0.64%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 83.9M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 67.21M
- Weight
- 0.08%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 60.25M
- Weight
- 0.03%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR- Market value
- 38.27M
- Weight
- 0.06%
- AUM
- 68.3B USD
- Expense ratio
- 0.05%
- Price / 1D
- $249.18+0.68%
Vanguard Extended Market ETFVXF- Market value
- 30.15M
- Weight
- 0.03%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Russell 2000 Value ETFIWN- Market value
- 24.45M
- Weight
- 0.17%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.81+0.45%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM- Market value
- 24.18M
- Weight
- 0.14%
- AUM
- 17.03B USD
- Expense ratio
- 0.03%
- Price / 1D
- $57.28+0.61%
Continue in GoAI
Research NEOGresearch.disclaimer











